MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Should be dispensed in moisture proof containers. Manufacturer states cannot be removed from original packaging due to sensitivity to moisture.

Provenance

This compatibility recommendation is derived from Slow Sodium 600mg tablets (Alturix Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-SR and XL 120mg capsules (Napp Pharmaceuticals Ltd), Angitil SR 120 capsules (Ethypharm UK Ltd), Viazem XL 120mg capsules (Thornton & Ross Ltd) and Zemtard 120 XL capsules (Galen Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-SR and XL 180mg capsules (Napp Pharmaceuticals Ltd), Angitil SR 180 capsules (Ethypharm UK Ltd), Viazem XL 180mg capsules (Thornton & Ross Ltd) and Zemtard 180 XL capsules (Galen Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 240mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 240 capsules (Ethypharm UK Ltd), Viazem XL 240mg capsules (Thornton & Ross Ltd) and Zemtard 240 XL capsules (Galen Ltd).

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 300mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 300 capsules (Ethypharm UK Ltd), Tildiem LA 300, Viazem XL 300mg capsules (Thornton & Ross Ltd) and Zemtard 300 XL capsules (Galen Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.